
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
Departments of 1 Otorhinolaryngology/Head & Neck Surgery and 2 Hemostasis and Transfusion Medicine, Heinrich-Heine-University, Düsseldorf, Germany; 3 Mannheim University Hospital, Mannheim, Germany; and 4 General Hospital, Fulda, Germany
Requests for reprints: Vera Balz, Department of Otorhinolaryngology/Head & Neck Surgery, Heinrich-Heine-University, Moorenstr. 5, D-40225 Düsseldorf, Germany. Phone: 49-211-811-8687; Fax: 49-211-811-9794/8880. E-mail: balz{at}uni-duesseldorf.de
A polymorphism at codon 72 of the human tumor suppressor p53 determines translation into either arginine or proline. Yet, the impact of this amino acid variability on the risk to develop malignant tumors, particularly carcinomas associated with human papilloma virus (HPV) infections, remains unresolved because of contradictory results. To address a potential correlation between the different genotypes and the manifestation of squamous cell carcinomas of the head and neck (SCCHN), we determined the p53 codon 72 in 193 healthy subjects and 122 unselected SCCHN with known HPV status. Furthermore, loss of allele-specific transcription was analyzed in p53 codon 72 heterozygous (Arg/Pro) SCCHN and correlated with HPV 16 and/or 18 E6 transcript expression. We found a moderately increased risk (odds ratio, 1.86; 95% confidence interval, 1.0-3.3) for individuals with germ line heterozygosity to develop SCC of the pharynx. On the other hand, p53 codon 72 polymorphic variants, most notably the Arg/Arg genotype, showed no association with the presence of HPV 16 and/or 18 E6 transcript. Moreover, there was no evidence for HPV-driven selection in SCCHN with allele-specific loss of transcription. Our data suggest that the p53 codon 72 polymorphism has a minor impact on the development of SCCHN.
This article has been cited by other articles:
![]() |
X. Ji, A. S. Neumann, E. M. Sturgis, K. Adler-Storthz, K. R. Dahlstrom, J. T. Schiller, Q. Wei, and G. Li p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers Carcinogenesis, April 1, 2008; 29(4): 875 - 879. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |